Carisma Therapeutics Overview

Life ScienceCompany

Where is Carisma Therapeutics headquartered?

Carisma Therapeutics is headquartered in Philadelphia, Pennsylvania.

What is Carisma Therapeutics’ revenue?

Carisma Therapeutics disclosed revenue of 20M USD for 2024 and 15M USD for 2023.

How many employees does Carisma Therapeutics have?

Carisma Therapeutics has 46 employees.

What sector is Carisma Therapeutics in?

Carisma Therapeutics is a life science company.

When was Carisma Therapeutics founded?

Carisma Therapeutics was founded in 2016.

Carisma Therapeutics

Carisma Therapeutics, Inc.

3675 Market Street, Suite 401,
Philadelphia, Pennsylvania 19104
United States,
(267) 491-6422
www.carismatx.com

Carisma Therapeutics is a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes CT-2401, which is in preclinical trail for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others. Carisma Therapeutics was founded in 2016 and is based in Philadelphia, Pennsylvania.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - - - 1 - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Top M&A Advisors

Financial Deals
BofA Securities
1
Evercore Group
1
Legal Deals
Wilmer Cutler Pickering Hale and Dorr
1

Try Mergr Free — See This and 220,830+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.